A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer
Abroad (travel likely)RecruitingEARLY_PHASE1
Conditions
Prostate Cancer · Radiation Toxicity · Urinary Complication
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Wilmot Cancer Institute, Rochester, New York, United States